Targeted therapy-first approach in LBCL may reduce chemotherapy need, maintaining high response rates and durability. Smart Stop trial showed a 90% overall response rate with targeted therapy, ...
Biomaterials have evolved from passive structural scaffolds to active intelligent systems that dynamically interact with the biological environment. Recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback